🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, Open-label, Randomised, Active-controlled, Parallel Grou...
Status
Terminated
Location
University of Alabama at Birmingham School of Medicine
Start Date
2016-05-26
Trial ID
NCT02688764
Treatments Being Tested
This is a Phase 3, randomised, active controlled, multicentre extension stu...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01464190
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of PA21 in...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-23
Trial ID
NCT01850602
Treatments Being Tested
The purpose of this study is to determine if Digoxin is affected by PA21....
Status
Completed
Location
ACRI - Phase 1
Start Date
2011-11
Trial ID
NCT01477411
The purpose of this study is to investigate efficacy and safety, when admin...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01852682
Treatments Being Tested
The purpose of this study is to determine if Furosemide is affected by PA21...
Status
Completed
Location
ACRI - Phase 1
Start Date
2011-07
Trial ID
NCT01438359
This is a single-center, prospective, open-label, controlled, randomized, c...
Status
Completed
Location
Ordensklinikum Linz GmbH Elisabethinen
Start Date
2017-06-09
Trial ID
NCT03010072
Treatments Being Tested
This is a Phase 3, randomised, active controlled, multicentre study to inve...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01324128
The purpose of this study is to determine if Warfarin is affected by PA21....
Status
Completed
Location
PRA International - Clinical Pharmacology Center
Start Date
2011-11
Trial ID
NCT01477424